Articles On Creso Pharma (ASX:CPH)

Former broker and Creso Pharma chair cops $850,000 fine for failed campaign to puff up medicinal cannabis play.

Adam Blumenthal, a former director of EverBlu Capital and Creso Pharma, has been ordered by the Federal Court to pay a fine of $850,000 and has been disqualified from managing corporations for five years, following action brought by the cor...

  Melodiol Global Health says 2023 been a milestone year with strong growth across portfolio Melodiol delivering on strategy to bring core operating subsidiaries into profitability Company says its strategic priority continues to be gener...

Melodiol subsidiary Health House International Australia delivers ~$1 million in revenue for October  Strong October performance continues progress from Q3 revenue of ~$3 million 12 month sales are ~$14 million, with EBITDA margin 12.7%...

Creso Pharma has changed its name to Melodiol Global Health (ASX:MEI) The cannabis-focused healthcare stock has seen a Canadian subsidiary post a 104 per cent increase in revenue vs Q3 CY22 The company reports it’s establishing a dom...

Melodial Global Health welcomes moves to reschedule marijuana to a lower risk category in US Analyst says potential US policy change “could catalyse a significant re-rating of cannabis stocks” Melodial monitoring situation closely in even...

Once again, medicinal cannabis company Creso Pharma (ASX: CPH) keeps pleasantly surprising us. Today they have REALLY surprised us by announcing they have acquired a Psychedelics company.

Creso Pharma (ASX: CPH) is listing on the US markets within weeks (via an OTC listing), but a similar company called MindMed is listing on the NASDAQ in 8 hours from now.

Creso Pharma (ASX: CPH) is edging closer to becoming part of our long term portfolio. CPH just raised $18M, which significantly shores up the balance sheet - another tick in the box for us as CPH builds trust to enter our long term portfoli...

Creso Pharma (ASX:CPH) today announced its listing in the US, and the market is opening in around 12 hours - the US pool of investors is huge and they have a big appetite for psychedelics and cannabis stocks.

Creso Pharma (ASX: CPH)’s acquisition target Halucenex just picked up an extra 10g of ‘hard-to-access’ synthetic psilocybin - and now has 22.3g in total.

Creso Pharma Ltd (ASX:CPH | OTC:COPHF) has just confirmed two consecutive quarters of record revenue growth. CPH posted $1.71M revenue this quarter - up from $1.38M in the previous quarter - that’s 24% growth.

Today Creso Pharma (ASX: CPH | OTC: COPHF) announced its plans to merge with a Canadian listed psychedelics company called Red Light Holland.

Today Creso Pharma’s (ASX:CPH) announced the acquisition of a range of CBD brand and product assets that deliver anti-inflammatory relief to professional and amateur athletes suffering from chronic muscle and joint pain.

Let's talk about the unbreakable bond between households and their pets, and about the companies that offer exposure -Demand for premium goods and services for pets is strong and resilient-Australia has one of the highest pet ownership rate...

Formerly Creso Pharma, Melodiol Global Health has a new name and a fresh drive to supply best-in-class psychedelic and cannabis products as it pursues growth in global markets. And the company is certainly chasing global growth, closing in...

Cannabis and psychedelics innovator Creso Pharma is excited to have signed an exclusive import deal with Swiss pharmaceutical manufacturer Apotheke Dr. Hysek AG for psilocybin and MDMA to enter the Australian market. As Australian psychiatr...

Cannabis and psychedelics innovator Creso Pharma is psyched to have signed an exclusive import deal with Swiss pharmaceutical manufacturer Apotheke Dr. Hysek AG for psilocybin and MDMA to enter the Australian market. As Australian psychiatr...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Creso Pharma subsidiary Mernova Medicinal has engaged a key advisory firm to progress its EU GMP licence application and fast-track exports to Europe and Australia. Cannabis play Creso Pharma (AX:CPH)  has announced its Canadian subsidiary...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

The world is experiencing a ‘shroom boom’ Psychedelics are expected to follow in cannabis’ explosive footstep And here’s how the ASX weed stocks have performed, sorted by winners over the past week   For years, people have frowned upon ps...

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

Stockhead’s In-Case-You-Missed-It highlights some of the strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentag...

Stockhead’s In-Case-You-Missed-It highlights some of the strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentag...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

The ASX continued its tragic decline, falling 1.05% over the course of a rubbish day InfoTech took trend-bucking to a whole new level, outperforming the market by 3.5% Something’s up at IncentiaPay, because it’s climbed 71.4% on absolutely...

The ASX fell this morning and – sadly – just never recovered. It’s down 0.64%. Aside from Happy Times among the lithium players, it’s been a total snoozefest Rubix Resources (ASX:RB6) takes bragging rights with a 41.6% hike for the day  ...

ASX sinks to -0.4% before slogging its way back to -0.22% for the day. Tech stocks were all over the shop but came out on top with +1.2%. Wildcat (ASX:WC8) was King of the Small Caps, adding 34.5% on no fresh news.   After sinking as low...

Research in Australia shows marijuana helps with chronic pain and insomnia The rules around getting prescriptions for medicinal cannabis A quick look at the winners and losers of ASX weed stocks   Sufferers of chronic pain and insomnia ha...

After a shaky start, the benchmark improved but still lost ground overall InfoTech did well to add 1.04%, but MAterials, Financials and Staples all weighed Standout winner was Rhythm Biosciences, up 88.6% on massive milestone news   Today...

After a feeble start, the benchmark has rallied to close at +0.1% Newcrest and Newmont shake hands on Australia’s biggest goldie takeover Westar Resources shines bright with a 47% price hike   As far as days on the ASX go, that definitely...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms....

Creso Pharma’s Green Goo pet care product range is expected to unlock multiple opportunities in Singapore, South Korea and Taiwan. Creso Pharma (ASX:CPH) has continued to advance its footprint across the Asia Pacific region after expanding...

Electric car-making giant Tesla has been crowned the most-searched-for stock globally, according to the latest study from City Index. Listed on the NASDAQ, Tesla topped the list with 3,569,400 monthly searches globally – 1.5 million more...

Trading platform City Index has released its list of the most-traded stocks worldwide. Taking out the top spot was Tesla, which averaged 3.5 million monthly searches globally – that’s over 1.5 million more than the runner-up, BP. When...

‘More of the same’ since lunchtime saw the benchmark land at -0.25% for the day Health Care coughed up a 1.09% lift while Financials weighed heavily on -0.71% Magnum Mining wins the Small Caps trophy with +44.1% thanks to Mitsubishi deal...

The deal with Groupon is also seen as a strategic fit, giving Creso access to Groupon’s rich database to help with future marketing efforts. Creso Pharma (ASX:CPH) announced that its wholly-owned US subsidiary, Sierra Sage Herbs (SSH), has...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

ASX falls 0.17% ahead of Chalmers dropping The Budget on the nation Financials led the pack today, adding 0.5% on an otherwise fairly moribund day Voltaic Strategic Resources climbs 188% on pre-assay lithium results at Ti Tree   The ASX h...

The ASX 200 benchmark has posted a solid slab of gains, up 0.78% for the day Energy and Materials have teamed up to bring the winnings, at +2.5% and +1.6% respectively Creso Pharma’s buy-out of HHI delivers strong backing from investors, u...

Stockhead’s In Case You Missed It highlights some of the strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage...

A deal to acquire Health House International will give Creso Pharma another source of revenue, as well as the opportunity to import and distribute medicines containing psilocybin and MDMA. Creso Pharma (ASX:CPH)’s Scheme of Arrangement to a...

Stockhead’s In Case You Missed It highlights some of the strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage...

As Australia becomes the first country in the world to officially recognise psychedelics as medicines, Creso Pharma’s subsidiary has positive early results from a  Phase-2 trial. Creso Pharma (ASX:CPH) has announced its wholly owned subsidi...

Studies confirm that cannabis relieves pain in cancer patients In addition, cannabis also improves sleep and cognitive function in cancer patients We take a look at the biggest movers in ASX weed stocks over the past week   It’s now offic...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms....

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms....

Creso Pharma’s subsidiary Mernova Medicinal Inc has been approved for an eighth Canadian province in Alberta by the Alberta Gaming, Liquor and Cannabis Commission (AGLC).   During 2022, Alberta had a total of 755 cannabis retailers which ge...